Advertisement

Topics

Companies Related to "Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)" [Most Relevant Company Matches] RSS

22:49 EDT 24th June 2019 | BioPortfolio

Here are the most relevant search results for "Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)" found in our extensive corporate database of over 50,000 company records.

Showing "Korean Registry Percutaneous EVAR With INCRAFT Stent Graft" Companies 1–25 of 199

Relevant

Endologix

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a leading cause of death in the United States and it ...


Lombard Medical Technologies PLC

Lombard Medical Technologies PLC is a global medical technology company focussed on providing innovative endovascular products which broaden clinicians’ treatment options and opportunities for treating more patients safely and more efficiently with Endovascular Aortic Repair (EVAR). Aorfix™ endovascular stent graft, Lombard Medical Technologies flagship product, addresses previousl...

Korea4Health

Korea4Health is the gateway to the internationally renowned Korean healthcare services prepared for the US patients exploring the most advanced and affordable healthcare solutions. Initiated by the public-private partnership, it is operated by KHIDI USA, Korean Government agency under the Ministry of Health and Welfare featuring the best medical procedu...


Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. (OTCQB: CVRS) is a global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The Company’s FDA-cleared CorPath 200 System is the first medical device that offers interventional cardiologists PCI procedure control from an interventional cockpit. With the CorPath System, Corindus Vascular R...

Aortica Corporation

Aortica Corporation was founded to design, manufacture, and market tools for treatment of patients with AAA disease who have aortic anatomy that limits their treatment options. While EVAR has become the gold standard for treatment of AAA disease, between 30-40% of patients are not candidates for EVAR because their aortic anatomy is structured in a manner t...

Gift of Life Marrow Registry

The Gift of Life Marrow Registry is a national non-profit headquartered in Boca Raton, Fla. The organization, established in 1991, is dedicated to curing blood cancer through marrow and stem cell donation. To learn more about the Gift of Life Marrow Registry, visit www.giftoflife.org.

CorNova Inc.

CorNova is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures, resulting in better patient outcomes without added procedure time, cost and patient risk. The company's FiberHalo(TM) stent deployment and post-dilatation angioplasty balloon catheters are designed to provide stent lumen area measurement within the angiopla...

Artegraft, Inc.

Incorporated in 1993, Artegraft, Inc. offers surgeons a biological alternative to synthetic grafts. Artegraft’s natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. Artegraft is also positioned as an alternative to a non-viable autogenous fistula. Artegraft was the first vascular graft a...

Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enl...

CMP Media Korea Co. Ltd.

CMP Media Korea organises XpoChem and XpoPharm, as well as the XpoChem and XpoPharm conferences, and as a Korean network of CMP organising world-renowned pharmaceutical and chemical events, CPhI Worldwide, CPhI Japan, CPhI China, CPhI India, CPhI South America, and Informex USA etc. provides opportunities for international companies to access the Korean market and assists with the development ...

Melior Pharmaceuticals Inc.

Bukwang Pharm. Co., Ltd. is a leading Korean pharmaceutical company listed on the Korean Stock Exchange [KRX:003000]. The company has been in business for over 50 years, and achieved US$130 million in sales in 2012. Sales are primarily derived from products licensed from Europe, the United States and Japan. The company is currently investing significant re...

Melior Pharmaceuticals I, Inc.

Bukwang Pharm. Co., Ltd. is a leading Korean pharmaceutical company listed on the Korean Stock Exchange [KRX:003000]. The company has been in business for over 50 years, and achieved US$130 million in sales in 2012. Sales are primarily derived from products licensed from Europe, the United States and Japan. The company is currently investing significant re...

Alveolus, Inc

Alveolus is an emerging leader in the development of non-vascular inter-ventional stent technology.Alveolus' advanced stent-ing technology is designed to enhance the quality of life for patients who suffer from malignant and benign pulmonary or gastrointestinal obstructive lumen diseases. The Company, whose products are developed by physicians for physicians, has developed a next-generation stent ...

Pharma Koreana Ltd.

Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorro...

SIRAKOSS Ltd

SIRAKOSS is developing nanosynthetic graft substitutes to facilitate complete bone repair and transform patient healing. The SIRAKOSS bone graft substitutes utilise advanced and proprietary understanding of nanostructures and nanochemistry to catalyze faster bone regeneration coupled with total graft resorption. SIRAKOSS was spun out of the University of A...

Lombard Medical, Inc.

Lombard Medical, Inc. will become the parent company of Lombard Medical Technologies PLC (“LMT”), a medical device company focused on device solutions for the $1.4 billion per annum abdominal aortic aneurysm repair market following a court approved scheme of arrangement. LMT’s lead product, Aorfix™, is an endovascular stent graft which has bee...

Corindus Vascular Robotics

Corindus designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s disposable medical device business model is enabled by a simple and low-cost console. The Company’s initial product, the CorPath™ system, is the world’s first to precisely drive coronary guidewires...

InnAVasc, Inc.

InnAVasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular and hemodialysis access. The Company’s first technology is an arteriovenous graft (AVG) modification that incorporates two multilayer cannulation chambers, with self-sealing technology, that are resist...

Cappella, Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD), specifically bifurcation disease. Cappella’s initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating...

Cappella Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella's initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating the sidebranch of diseased coronary ...

Brain Health Registry

The Brain Health Registry (BHR) is a groundbreaking free, online platform designed to speed the path to cures for Alzheimer’s, Parkinson's, depression, PTSD, mild cognitive impairment and other brain disorders. BHR gathers cognitive data from volunteers who have registered and completed questionnaires and cognitive tests on the BHR website. BHR aim...

Tryton Medical, Inc.

Tryton Medical, Inc., located in Durham, N.C., is a leading developer of novel stent systems for the treatment of bifurcation lesions. The company's Side Branch Stent System, approved for sale in Europe, is designed to offer a dedicated strategy for treating these challenging cases. The privately held company is backed by Spray Ventures, PTV Sciences, and ...

Flexible Stenting Solutions, Inc.

Flexible Stenting Solutions Inc. (FSS) is a leading developer of third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. Its fully connected stent has coupled technology with clinical needs by providing an atraumatic, highly durable and fatigue resistant stent with superior radial stiffness, flexibility and conformability. ...

Elixir Medical Corporation

Elixir Medical is developing a wide range of drug and device platforms for vascular therapies. These include drug eluting stent systems with durable and bioabsorbable polymers, and fully bioresorbable drug eluting stent systems.

ApaTech, Inc.

ApaTech is a world leader in synthetic bone graft technologies. Our mission is to provide surgeons with superior, proprietary, bone graft solutions, helping them improve clinical outcomes and patient quality of life. ApaTech was formed in 2001 with the rights to bone materials research and IP from London and Cambridge Universities. The company retains pipeline agreements with founding inventors, i...


More From BioPortfolio on "Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks